Calendar Stocks

/

Stocks
Vertex Pharmaceuticals
Business Segments
Business Segments
Interest income, net

Interest income, net

Vertex Pharmaceuticals·Business Segments·1 segment

Breakdown

Segment	Q1 '26
Business Segments	$114.80M
Total	$114.80M

Segments

Business SegmentsView metric

Navigation

Earnings Calendar
Stocks

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

OpenCapital